News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Investing.com2d agoneutral
S&P revises Boston Scientific outlook to negative on franchise pressuresMedTech Dive3d agoneutral
Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump developmentPR Newswire4d agoneutral
RevMedica Appoints Former Boston Scientific Executive Mike Jones as Chief Executive OfficerSimply Wall St.4d agoneutral
Boston Scientific (BSX) Secures $455 Million For A Next Generation Heart PumpMedical Device Network5d agoneutral
Spinal cord stimulator lawsuits surge: what is going wrong?Medical Device Network5d agoneutral
Boston Scientific and Blackstone agree on $455m VITALYST heart pump dealHospital Management5d agoneutral
Boston Scientific and Blackstone agree on $455m VITALYST heart pump dealMT Newswires9d agoneutral
Rothschild & Co Redburn Adjusts Boston Scientific Price Target to $60 From $78MT Newswires9d agoneutral
TD Cowen Downgrades Boston Scientific to Hold From Buy Price Target is $46Simply Wall St.10d agobearish
Cyberattack Fallout Could Be A Game Changer For Boston Scientific (BSX)Simply Wall St.10d agobullish
Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI Push